DiscoverNeurology – Dr. Barry DworkinLilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.
Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.

Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.

Update: 2023-05-05
Share

Description

Medical Mythbusting Commentary for May 5, 2023









Source:
Lilly drug slows Alzheimer’s progression by 35 per cent in trial





Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.

Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.

Dr. Barry Dworkin